Skip to main content
Clinical Trials/NCT01988389
NCT01988389CompletedNot Applicable

Effect of Apples Consumption on Blood Lipid Levels,Vascular Function and Gut Health in Moderate Hypercholesterolemic Subjects

University of Reading1 site in 1 country40 target enrollmentStarted: September 1, 2013Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
40
Locations
1
Primary Endpoint
Changes in blood lipid levels

Study Overview

Brief Summary

There is now considerable scientific evidence that a diet rich in fruits and vegetables could improve human health. Apples are among the most frequently consumed fruits in the world. Epidemiological studies have linked frequent apple consumption with several health benefits including a reduced risk of cardiovascular disease. Apples are an important source of polyphenols and fiber and their beneficial effects could be attributed to this content; however, their impact on our health is not clear. Although, there are some studies that have reported cholesterol lowering effects the results are inconsistent. Furthermore, few studies have explored the impact on vascular function and gut microbiota. The objective of the current study is to assess whether a regular apple consumption, reduces total cholesterol levels, improves vascular function and gut microbiota profile in mildly hypercholesterolemic subjects compared with a control, sugar matched commercial clear apple juice squash.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
23 Years to 69 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Mildly hypercholesterolemic: TC>5.2 and <7.9 mmol/L
  • •BMI: 20-35
  • •Age: 23-69
  • •Normal liver and kidney function

Exclusion Criteria

  • •Drug treatment for hyperlipidaemia, hypertension, inflammation and hypercoagulation.
  • •Vegetarians.
  • •History of alcohol misuse.
  • •History of food allergy (e.g. apples, sulphites).
  • •Taking antibiotics for the previous 3 months.
  • •Taking phytochemical, antioxidant, fish oil supplements, or prebiotic/probiotic preparations unless willing to stop for the study period and after a 4 week wash out period (8 weeks for fish oil).
  • •Females who are pregnant, lactating, or if of reproductive age and not using a reliable form of contraception (including abstinence).
  • •Medical history of cardiovascular disease including coronary heart disease (angina and heart attack) and stroke (in the past 12 months).
  • •Family history of cardiovascular disease (their father or brother was under 55 or their mother or sister was under 65 when they were diagnosed with cardiovascular disease).
  • •Diabetes mellitus.
  • •Kidney, liver, pancreas or gastrointestinal diseases.
  • •Hematologic disorders (i.e. anaemia; men:haemoglobin<13.8g/dl (8.56mmol/L) and women<12.1 g/dl (5.51mmol/L)).
  • •Planning a weight reducing regime.
  • •Parallel participation in another dietary intervention study.

Arms & Interventions

whole apples

Experimental

Subjects are asked to consume 2 apples a day for 8 weeks in addition to their habitual diet

Intervention: whole apples (WA) (Dietary Supplement)

apple juice squash

Other

Subjects are asked to consume 100 ml of apple juice squash (recommended dilution with water up to 500 ml) for 8 weeks in addition to their habitual diet. The apple juice is used as a sugar matched control.

Intervention: apple juice (AJ) (Dietary Supplement)

Outcomes

Primary Outcomes

Changes in blood lipid levels

Time Frame: Baseline and assessment at 8 weeks for each intervention arm including a 4 week wash out period.

Secondary Outcomes

  • Evaluation of endothelial function by using laser doppler iontophoresis (LDI)(Baseline and assessment at 8 weeks for each intervention arm.)
  • Changes in vascular stiffness by pulse wave analysis (PWA)(Baseline and assessment at 8 weeks for each intervention arm)
  • Changes in faecal bacterial population(Baseline and assessment at 8 weeks for each intervention arm)
  • Ambulatory blood pressure(Baseline and assessment at 8 weeks for each intervention arm)
  • Changes in inflammatory, endothelial function and oxidative stress markers(Baseline and assessment at 8 weeks for each intervention arm)
  • Changes in insulin resistance and gut hormones(Baseline and assessment at 8 weeks for each intervention arm)
  • Metabolomic analysis for the determination of the low molecular weight metabolite profiles in the biological fluids (blood, urine and faecal sample).(Baseline and assessment at 8 weeks for each intervention arm)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Julie Lovegrove

Professor

University of Reading

Study Sites (1)

Loading locations...

Similar Trials